E-Mail
Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients. The probability of cure depends largely on the type of cancer tumor and the stage at which the disease is discovered. Accurate means of diagnosis in the early stages is key to saving lives.
New Israeli research is being conducted to develop a hypoxia radioactive marker (a phenomenon of lack of oxygen in cells) based on the Copper 64 isotope to identify oxygen-deficient cells. Studies have shown that oxygen concentration in the cell is directly related to the aggressiveness of cancerous tumors. The hypoxia radioactive marker will not only determine if the tumor is malignant or benign, but also how aggressive it is through a single image, eliminating the need for a biopsy.
Hypoxia radioactive marker will detect aggressiveness of tumors, eliminating the need for biopsy
Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients. The probability of cure depends largely on the type of cancer tumor and the stage at which the disease is discovered. Accurate means of diagnosis in the early stages is key to saving lives.
New Israeli research is being conducted to develop a hypoxia radioactive marker (a phenomenon of lack of oxygen in cells) based on the Copper 64 isotope to identify oxygen-deficient cells. Studies have shown that oxygen concentration in the cell is directly related to the aggressiveness of cancerous tumors. The hypoxia radioactive marker will not only determine if the tumor is malignant or benign, but also how aggressive it is through a single image, eliminating the need for a biopsy.
Israeli Researchers Develop Marker to Detect Aggressive Cancerous Tumors The Media Line Staff 04/11/2021
Israeli researchers have developed a radioactive marker to detect small and aggressive cancerous tumors. The research on a hypoxia radioactive marker, which identifies oxygen-deficient cells, was developed by Isotopia Molecular Imaging Ltd., and led by Prof. Sharon Ruthstein from the Department of Chemistry at Bar-Ilan University.
Studies have shown that oxygen concentration in the cell is directly related to the aggressiveness of cancerous tumors. The hypoxia radioactive marker, which is based on the Copper 64 isotope, will not only determine if the tumor is malignant or benign, but also how aggressive it is through a single image, eliminating the need for a biopsy, the university’s BIRAD – Research and Development Company Ltd. said in a statement.
Israeli Researchers Develop Radioactive Marker to Detect Aggressive Cancerous Tumors | The Jewish Press - JewishPress com | Jewish Press News Desk | 29 Nisan 5781 – April 11, 2021 jewishpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jewishpress.com Daily Mail and Mail on Sunday newspapers.